168 related articles for article (PubMed ID: 28295164)
21. PSORS2 is due to mutations in CARD14.
Jordan CT; Cao L; Roberson ED; Pierson KC; Yang CF; Joyce CE; Ryan C; Duan S; Helms CA; Liu Y; Chen Y; McBride AA; Hwu WL; Wu JY; Chen YT; Menter A; Goldbach-Mansky R; Lowes MA; Bowcock AM
Am J Hum Genet; 2012 May; 90(5):784-95. PubMed ID: 22521418
[TBL] [Abstract][Full Text] [Related]
22. Pustular psoriasis and related pustular skin diseases.
Bachelez H
Br J Dermatol; 2018 Mar; 178(3):614-618. PubMed ID: 29333670
[TBL] [Abstract][Full Text] [Related]
23. Pustular Psoriasis: The Dawn of a New Era.
Bachelez H
Acta Derm Venereol; 2020 Jan; 100(3):adv00034. PubMed ID: 31971600
[TBL] [Abstract][Full Text] [Related]
24. The genetic basis for most patients with pustular skin disease remains elusive.
Mössner R; Wilsmann-Theis D; Oji V; Gkogkolou P; Löhr S; Schulz P; Körber A; Prinz JC; Renner R; Schäkel K; Vogelsang L; Peters KP; Philipp S; Reich K; Ständer H; Jacobi A; Weyergraf A; Kingo K; Kõks S; Gerdes S; Steinz K; Schill T; Griewank KG; Müller M; Frey S; Ebertsch L; Uebe S; Sticherling M; Sticht H; Hüffmeier U
Br J Dermatol; 2018 Mar; 178(3):740-748. PubMed ID: 28887889
[TBL] [Abstract][Full Text] [Related]
25. Rare CARD14 missense variants associated with palmoplantar pustulosis (PPP) in the Chinese Han population.
Fu F; Sun Y; Zhao Q; Yu G; Yang Q; Liu H; Zhang F
Eur J Dermatol; 2019 Feb; 29(1):99-100. PubMed ID: 30998217
[No Abstract] [Full Text] [Related]
26. Clinical response to ustekinumab in CARD14-associated papulosquamous eruption (CAPE) with a new missense mutation in CARD14: a case report and systematic review.
Nieto-Benito LM; Baniandrés-Rodríguez O; Moreno-Torres A; Hernández-Martín A; Torrelo-Fernández A; Campos-Domínguez M
J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):e728-e730. PubMed ID: 32349169
[No Abstract] [Full Text] [Related]
27. A case report of Dowling-Degos disease caused by POFUT1 exon deletion with possible coexistent CARD14 mutation-related psoriasis.
Liu Z; Zhu Z; Luo J; Yang B
J Eur Acad Dermatol Venereol; 2022 Aug; 36(8):e643-e645. PubMed ID: 35340079
[No Abstract] [Full Text] [Related]
28. Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation.
Podlipnik S; Castellanos-Moreira R; Florez-Enrich H; Arostegui JI; Mascaró JM
Australas J Dermatol; 2018 Feb; 59(1):e70-e73. PubMed ID: 28776328
[TBL] [Abstract][Full Text] [Related]
29. CARD14-Mediated Activation of Paracaspase MALT1 in Keratinocytes: Implications for Psoriasis.
Van Nuffel E; Schmitt A; Afonina IS; Schulze-Osthoff K; Beyaert R; Hailfinger S
J Invest Dermatol; 2017 Mar; 137(3):569-575. PubMed ID: 27939769
[TBL] [Abstract][Full Text] [Related]
30. CARD14-associated papulosquamous eruption: A spectrum including features of psoriasis and pityriasis rubra pilaris.
Craiglow BG; Boyden LM; Hu R; Virtanen M; Su J; Rodriguez G; McCarthy C; Luna P; Larralde M; Humphrey S; Holland KE; Hogeling M; Hidalgo-Matlock B; Ferrari B; Fernandez-Faith E; Drolet B; Cordoro KM; Bowcock AM; Antaya RJ; Ashack K; Ashack RJ; Lifton RP; Milstone LM; Paller AS; Choate KA
J Am Acad Dermatol; 2018 Sep; 79(3):487-494. PubMed ID: 29477734
[TBL] [Abstract][Full Text] [Related]
31. Clinical response to ustekinumab in familial pityriasis rubra pilaris caused by a novel mutation in CARD14.
Eytan O; Sarig O; Sprecher E; van Steensel MA
Br J Dermatol; 2014 Aug; 171(2):420-2. PubMed ID: 24641799
[No Abstract] [Full Text] [Related]
32. Excellent response to secukinumab in an infant with severe generalized pustular psoriasis.
López-Sánchez C; Falla LM; Roé-Crespo E; Arostegui JI; Mozos A; Bernal S; Iznardo H; Baselga-Torres E
J Dermatol; 2021 Jun; 48(6):907-910. PubMed ID: 33543522
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation in a CARD14-associated papulosquamous eruption.
Li N; Tao J; Zhang J; Liu Z; Yu P
Pediatr Dermatol; 2023; 40(4):706-709. PubMed ID: 36724903
[TBL] [Abstract][Full Text] [Related]
34. [Molecular identification of the PSORS2 locus: mutations and polymorphisms in CARD14 gene].
Dereure O
Ann Dermatol Venereol; 2013 Jan; 140(1):65-6. PubMed ID: 23328365
[No Abstract] [Full Text] [Related]
35. A viewpoint on the genetic determinants of generalised pustular psoriasis.
Capon F
Exp Dermatol; 2023 Aug; 32(8):1188-1193. PubMed ID: 36645252
[TBL] [Abstract][Full Text] [Related]
36. Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
Klein B; Treudler R; Dumann K; Boldt A; Schumann I; Simon JC; Kunz M
Br J Dermatol; 2022 Sep; 187(3):419-422. PubMed ID: 35262907
[TBL] [Abstract][Full Text] [Related]
37. Common and rare CARD14 gene variants affect the antitumour necrosis factor response among patients with psoriasis.
Coto-Segura P; González-Fernández D; Batalla A; Gómez J; González-Lara L; Queiro R; Alonso B; Iglesias S; Coto E
Br J Dermatol; 2016 Jul; 175(1):134-41. PubMed ID: 26854129
[TBL] [Abstract][Full Text] [Related]
38. An update on genetic basis of generalized pustular psoriasis (Review).
Zhou J; Luo Q; Cheng Y; Wen X; Liu J
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33955502
[TBL] [Abstract][Full Text] [Related]
39. Gain of function p.E138A alteration in Card14 leads to psoriasiform skin inflammation and implicates genetic modifiers in disease severity.
Sundberg JP; Pratt CH; Silva KA; Kennedy VE; Qin W; Stearns TM; Frost J; Sundberg BA; Bowcock AM
Exp Mol Pathol; 2019 Oct; 110():104286. PubMed ID: 31323190
[TBL] [Abstract][Full Text] [Related]
40. Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
Howes A; O'Sullivan PA; Breyer F; Ghose A; Cao L; Krappmann D; Bowcock AM; Ley SC
Biochem J; 2016 Jun; 473(12):1759-68. PubMed ID: 27071417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
